Lukas Bubendorf currently serves as a professor and pathologist at the Institute of Pathology, University Hospital Basel, Switzerland. He is actively involved in research areas including non-small cell lung cancer (NSCLC), epidermal growth factor receptor (EGFR), radiotherapy, targeted therapy in lung cancer as well as biomarkers of lung cancer for the early detection of this disease. At WCLC 2017, he made a speech and shared his findings on “Molecular Testing Using Cytology Specimens”.
